Spelling suggestions: "subject:"heart valves - cotransplantation."" "subject:"heart valves - autransplantation.""
1 |
Fibroblast viability in the allograft heart valve leafletWheatley, David John 03 May 2017 (has links)
No description available.
|
2 |
The transplantation of heart valvesDuran, C. M. G. January 1965 (has links)
No description available.
|
3 |
The implications of transcatheter aortic valve implantation (TAVI) adoptionLeung, Wing-ki, Vikki., 梁頴琪. January 2012 (has links)
Aortic stenosis is a life-threatening valvular heart disease. At the onset of symptoms, a patient’s prognosis becomes poor and the risk of death rapidly increases. Aortic valve replacement surgery remains the gold standard in treatment for aortic stenosis. However, in the total population of patients with severe aortic stenosis, about one third are deemed inoperable due to their high surgical risk. In recent years, the development of transcatheter aortic valve implantation (TAVI), a non-invasive heart valve replacement procedure brought hope for the elderly, high-risk and inoperable aortic stenosis patient population pool. A literature review was performed to examine the safety, efficacy and effectiveness evidence for transcatheter aortic valve treatment option. The results showed that TAVI is a safe treatment option, however the effectiveness for the whole patient population is unknown. The adoption of this alternative treatment option is certainly coupled with multiple dimension of impact from a public health perspective. It remains inconclusive whether TAVI is an effective treatment option to be adopted. / published_or_final_version / Public Health / Master / Master of Public Health
|
Page generated in 0.0975 seconds